The Roadmap: Belgium
Cardiomyopathies are often neglected despite the significant burden they pose on individuals and society in Belgium and other countries. However, through enhanced awareness, detection, and healthcare provision, the impact and prevalence of those diseases could be reduced.
The Belgian Cardiomyopathies Matter Roadmap aims to address this by raising awareness and ensuring they receive positive policy attention from healthcare system decision-makers and KOLs. This Roadmap transposes the European priorities to the Belgian context to provide a framework for policy changes in Belgium endorsed by leading experts in the field through the Belgian Cardiomyopathies Matter Network.
Launched in February 2024, the Belgian Cardiomyopathies Matter Roadmap was developed with contributions from the following experts of the field of cardiology.
Expert contributors
Prof Stefan Janssens
Chairman, Department of Cardiovascular Diseases, University Hospitals Leuven, Leuven, Belgium
Prof Antoine Bondue
Head of the Department of Cardiology and Rare Disease Director, Hôpital Universitaire de Bruxelles, Hôpital Erasme, ULB
Prof Emeline Van Craenenbroeck
Cardiologist and Coordinator of the Heart Failure Unit, Universitair Ziekenhuis Antwerpen, UZA
News
SAVE THE DATE: Cardiomyopathies Matter 2024 Summit on November 12th Cardiomyopathies Matter Summit 2024
Cardiomyopathies Matter (CMatter) is delighted to announce that its 2024…
Dr Tootie Bueser presents a Cardiomyopathies Matter poster at ACNAP 2024
On the 14th of June 2024, Cardiomyopathies Matter (CMatter) steering…
Belgian Cardiomyopathies Matter Roadmap
Cardiomyopathies, a group of diseases affecting the heart muscle, are…




